0
     

Report Added
Report already added
Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity

Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity

Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region.

Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Small Molecules
•Large Molecules
oLC-MS Studies
oImmunoassays
oOther Large Molecule Tests

Based Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Bioavailability and Bioequivalence Studies
•Pharmacokinetics (PK)
•Pharmacodynamics (PD)
•Absorption, Distribution, Metabolism, Excretion (ADME)
•Other Applications

By Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Cell-based Assays
oBacterial Cell-based Assays
oViral Cell-based Assays
•Virology Testing
oIn Vitro Virology Testing
oIn Vivo Virology Testing
oSpecies-Specific Viral PCR Assays
•Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
oBacterial Serology, Immunogenicity, and Neutralizing Antibodies
oViral Serology, Immunogenicity, and Neutralizing Antibodies
•Method Development Optimization and Validation (MDOV)
•Biomarker Testing
•Pharmacokinetic Testing
•Other Test Types

By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Sample Preparation
oProtein Precipitation
oLiquid-liquid Extraction (LLE)
•Sample Analysis
oHyphenated Technique
oChromatographic Technique
oElectrophoresis
oLigand Binding Assay
oMass Spectrometry
oNuclear Magnetic Resonance
•Other Workflow Processes

By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Oncology
•Neurology
•Infectious Diseases
•Gastroenterology
•Cardiology
•Other Therapeutic Areas

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Pharma and Biopharma Companies
•Contract Development and Manufacturing Organizations (CDMOs)
•Contract Research Organizations (CROs)

Geographically, the following regions together with the listed national/local markets are fully investigated:
•North America (U.S., Canada, and Mexico)
•Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•South America (Brazil, Chile, Argentina, Rest of South America)
•MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction11
1.1 Industry Definition and Research Scope11
1.1.1 Industry Definition11
1.1.2 Research Scope12
1.2 Research Methodology15
1.2.1 Overview of Market Research Methodology15
1.2.2 Market Assumption16
1.2.3 Secondary Data16
1.2.4 Primary Data16
1.2.5 Data Filtration and Model Design17
1.2.6 Market Size/Share Estimation18
1.2.7 Research Limitations19
1.3 Executive Summary20
2 Market Overview and Dynamics23
2.1 Market Size and Forecast23
2.1.1 Impact of COVID-19 on World Economy24
2.1.2 Impact of COVID-19 on the Market26
2.2 Major Growth Drivers31
2.3 Market Restraints and Challenges34
2.4 Emerging Opportunities and Market Trends37
2.5 Porter’s Fiver Forces Analysis41
3 Segmentation of Global Market by Molecule Type45
3.1 Market Overview by Molecule Type45
3.2 Small Molecules47
3.3 Large Molecules48
3.3.1 LC-MS Studies49
3.3.2 Immunoassays50
3.3.3 Other Large Molecule Tests51
4 Segmentation of Global Market by Application52
4.1 Market Overview by Application52
4.2 Bioavailability and Bioequivalence Studies54
4.3 Pharmacokinetics (PK)55
4.4 Pharmacodynamics (PD)56
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)57
4.6 Other Applications58
5 Segmentation of Global Market by Test Type59
5.1 Market Overview by Test Type59
5.2 Cell-based Assays61
5.2.1 Bacterial Cell-based Assays62
5.2.2 Viral Cell-based Assays63
5.3 Virology Testing64
5.3.1 In Vitro Virology Testing65
5.3.2 In Vivo Virology Testing66
5.3.3 Species-Specific Viral PCR Assays67
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)68
5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies69
5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies70
5.5 Method Development Optimization and Validation (MDOV)71
5.6 Biomarker Testing72
5.7 Pharmacokinetic Testing73
5.8 Other Test Types74
6 Segmentation of Global Market by Workflow Process75
6.1 Market Overview by Workflow Process75
6.2 Sample Preparation77
6.2.1 Protein Precipitation78
6.2.2 Liquid-liquid Extraction (LLE)79
6.2.3 Solid Phase Extraction (SPE)80
6.3 Sample Analysis81
6.3.1 Hyphenated Technique83
6.3.2 Chromatographic Technique84
6.3.3 Electrophoresis85
6.3.4 Ligand Binding Assay86
6.3.5 Mass Spectrometry87
6.3.6 Nuclear Magnetic Resonance88
6.4 Other Workflow Processes89
7 Segmentation of Global Market by Therapeutic Area90
7.1 Market Overview by Therapeutic Area90
7.2 Oncology92
7.3 Neurology93
7.4 Infectious Diseases94
7.5 Gastroenterology95
7.6 Cardiology96
7.7 Other Therapeutic Areas97
8 Segmentation of Global Market by End User98
8.1 Market Overview by End User98
8.2 Pharma and Biopharma Companies100
8.3 Contract Development and Manufacturing Organizations (CDMOs)101
8.4 Contract Research Organizations (CROs)102
9 Segmentation of Global Market by Region103
9.1 Geographic Market Overview 2021-2031103
9.2 North America Market 2021-2031 by Country107
9.2.1 Overview of North America Market107
9.2.2 U.S.111
9.2.3 Canada114
9.2.4 Mexico116
9.3 European Market 2021-2031 by Country118
9.3.1 Overview of European Market118
9.3.2 Germany122
9.3.3 U.K.124
9.3.4 France126
9.3.5 Spain128
9.3.6 Italy130
9.3.7 Russia132
9.3.8 Rest of European Market134
9.4 Asia-Pacific Market 2021-2031 by Country136
9.4.1 Overview of Asia-Pacific Market136
9.4.2 Japan140
9.4.3 China143
9.4.4 Australia145
9.4.5 India147
9.4.6 South Korea149
9.4.7 Rest of APAC Region151
9.5 South America Market 2021-2031 by Country153
9.5.1 Argentina156
9.5.2 Brazil158
9.5.3 Chile160
9.5.4 Rest of South America Market162
9.6 MEA Market 2021-2031 by Country163
9.6.1 UAE166
9.6.2 Saudi Arabia168
9.6.3 South Africa170
9.6.4 Other National Markets172
10 Competitive Landscape173
10.1 Overview of Key Vendors173
10.2 New Product Launch, Partnership, Investment, and M&A176
10.3 Company Profiles177
Charles River Laboratories International Inc.177
Covance Inc.179
Eurofins Scientific180
ICON PLC181
Intertek Group PLC182
IQVIA Holdings, Inc.183
Laboratory Corporation of America Holdings184
Medpace Holdings, Inc.185
Pace Analytical Services LLC.186
Parexel International Corporation187
PPD Inc.188
SGS SA189
Syneos Health, LLC190
Toxikon Corporation191
WuXi Apptech Co., Ltd.192
RELATED REPORTS193

List of Tables:

Table 1. Snapshot of Global Bioanalytical Testing Services Market in Balanced Perspective, 2021-203121
Table 2. World Economic Outlook, 2021-203125
Table 3. World Health Spending by Region, $ bn, 2013-202030
Table 4. Main Product Trends and Market Opportunities in Global Bioanalytical Testing Services Market37
Table 5. Global Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn45
Table 6. Global Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn48
Table 7. Global Bioanalytical Testing Services Market by Application, 2021-2031, $ mn52
Table 8. Global Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn59
Table 9. Global Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn61
Table 10. Global Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn64
Table 11. Global Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn68
Table 12. Global Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn75
Table 13. Global Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn77
Table 14. Global Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn82
Table 15. Global Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn90
Table 16. Global Bioanalytical Testing Services Market by End User, 2021-2031, $ mn98
Table 17. Global Bioanalytical Testing Services Market by Region, 2021-2031, $ mn104
Table 18. Leading National Bioanalytical Testing Services Market, 2021 and 2031, $ mn106
Table 19. North America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn109
Table 20. U.S. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn113
Table 21. U.S. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn113
Table 22. U.S. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn113
Table 23. Canada Bioanalytical Testing Services Market by Application, 2021-2031, $ mn115
Table 24. Canada Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn115
Table 25. Canada Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn115
Table 26. Mexico Bioanalytical Testing Services Market by Application, 2021-2031, $ mn117
Table 27. Mexico Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn117
Table 28. Mexico Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn117
Table 29. Europe Bioanalytical Testing Services Market by Country, 2021-2031, $ mn121
Table 30. Germany Bioanalytical Testing Services Market by Application, 2021-2031, $ mn123
Table 31. Germany Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn123
Table 32. Germany Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn123
Table 33. U.K. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn125
Table 34. U.K. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn125
Table 35. U.K. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn125
Table 36. France Bioanalytical Testing Services Market by Application, 2021-2031, $ mn127
Table 37. France Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn127
Table 38. France Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn127
Table 39. Spain Bioanalytical Testing Services Market by Application, 2021-2031, $ mn129
Table 40. Spain Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn129
Table 41. Spain Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn129
Table 42. Italy Bioanalytical Testing Services Market by Application, 2021-2031, $ mn131
Table 43. Italy Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn131
Table 44. Italy Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn131
Table 45. Russia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn133
Table 46. Russia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn133
Table 47. Russia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn133
Table 48. Bioanalytical Testing Services Market in Rest of Europe by Country, 2021-2031, $ mn135
Table 49. APAC Bioanalytical Testing Services Market by Country, 2021-2031, $ mn138
Table 50. Japan Bioanalytical Testing Services Market by Application, 2021-2031, $ mn142
Table 51. Japan Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn142
Table 52. Japan Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn142
Table 53. China Bioanalytical Testing Services Market by Application, 2021-2031, $ mn144
Table 54. China Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn144
Table 55. China Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn144
Table 56. Australia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn146
Table 57. Australia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn146
Table 58. Australia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn146
Table 59. India Bioanalytical Testing Services Market by Application, 2021-2031, $ mn148
Table 60. India Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn148
Table 61. India Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn148
Table 62. South Korea Bioanalytical Testing Services Market by Application, 2021-2031, $ mn150
Table 63. South Korea Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn150
Table 64. South Korea Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn150
Table 65. Bioanalytical Testing Services Market in Rest of APAC by Country/Region, 2021-2031, $ mn152
Table 66. South America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn155
Table 67. Argentina Bioanalytical Testing Services Market by Application, 2021-2031, $ mn157
Table 68. Argentina Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn157
Table 69. Argentina Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn157
Table 70. Brazil Bioanalytical Testing Services Market by Application, 2021-2031, $ mn159
Table 71. Brazil Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn159
Table 72. Brazil Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn159
Table 73. Chile Bioanalytical Testing Services Market by Application, 2021-2031, $ mn161
Table 74. Chile Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn161
Table 75. Chile Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn161
Table 76. MEA Bioanalytical Testing Services Market by Country, 2021-2031, $ mn165
Table 77. UAE Bioanalytical Testing Services Market by Application, 2021-2031, $ mn167
Table 78. UAE Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn167
Table 79. UAE Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn167
Table 80. Saudi Arabia Bioanalytical Testing Services Market by Application, 2021-2031, $ mn169
Table 81. Saudi Arabia Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn169
Table 82. Saudi Arabia Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn169
Table 83. South Africa Bioanalytical Testing Services Market by Application, 2021-2031, $ mn171
Table 84. South Africa Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn171
Table 85. South Africa Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn171
Table 86. Charles River Laboratories International Inc.: Company Snapshot177
Table 87. Charles River Laboratories International Inc.: Business Segmentation178
Table 88. Charles River Laboratories International Inc.: Product Portfolio178

Report Title: Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW